• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】44704

【品名】ethyl (E)-4-(diethoxyphosphoryl)-3-methyl-2-butenoate

【CA登记号】41891-54-7

【 分 子 式 】C11H21O5P

【 分 子 量 】264.258502

【元素组成】C 50% H 8.01% O 30.27% P 11.72%

与该中间体有关的原料药合成路线共 8 条

合成路线1

该中间体在本合成路线中的序号:(XIII)

Alitretinoin esters (IIa) and (IIb) can be prepared by a variety of methods. Horner-Emmons reaction of either the ionylideneacetaldehyde (V) (3, 4) or its tricarbonyl iron complex (XII) (5) with diethyl 3-(ethoxycarbonyl)-2-methylprop-2-enylphosphonate (XIII), optionally followed by decomplexation using CuCl2 in EtOH, provides alitretinoin ethyl ester (IIa). Alternatively, Wittig reaction of aldehyde (V) with iodomethylenetriphenylphosphorane, followed by in situ elimination of HI using an excess of sodium hexamethyldisilazide, and then addition of lithium butyl(tributylstannyl)cyanocuprate to the obtained terminal acetylene, leads to the unstable vinyl stannane (XIV). Subsequent Stille coupling of crude stannane (XIV) with the vinyl triflate (XV) (derived from ethyl acetoacetate) furnishes the target 9-cis-retinoate (IIa) (6). In a different route, the addition of lithium butyl(tributylstannyl)-cyanocuprate (generated from Bu3SnH, BuLi and CuCN) to (Z)-3-methyl-2-penten-4-yn-1-ol (XVI) and MnO2 oxidation of the allyl alcohol function results in the stannyl dienal (XVII). Subsequent Horner-Emmons reaction of aldehyde (XVII) with phosphonate (XIII) followed by iododestannylation of the obtained adduct furnishes the tetraenyl iodide (XVIII). 2,2,6-Trimethylcyclohexanone (XIX) is reacted with hydrazine hydrate and Et3N in boiling EtOH to produce the corresponding hydrazone, which is converted to vinyl iodide upon treatment with iodine and DBN. Metalation of the vinyl iodide with t-BuLi followed by trapping with trimethyl borate generates an unstable intermediate, assumed to be the boronic ester (XX). Then, Suzuki coupling between the in situ-generated boronate (XX) and freshly prepared tetraenyl iodide (XVIII) provides the target cis-retinoate (IIa) in satisfactory yields (7, 8). Two related synthetic strategies, useful for introducing tritium labeling onto the cyclohexenyl ring of (II), are based on the catalytic hydrogenation of the conjugated cyclohexadiene compound (XXIa) or its nonconjugated analogue (XXIb) in the presence of Rh(PPh3)3Cl (9). Compound (IIb), along with some labeled derivatives, can be prepared by the following route. Condensation of 2,2,6-trimethylcyclohexanone (XIX) with the bromomagnesium acetylide of (Z)-3-methyl-2-penten-4-yn-1-ol (XVI) affords the propargylic alcohol adduct (XXII). After reduction of the triple bond of (XXII) with LiAlH4, oxidation of the primary alcohol group using MnO2 in dry CH2Cl2 yields the hydroxy dienal (XXIII). Wittig olefination of aldehyde (XXIII) with (methoxycarbonylmethylene)triphenylphosphorane followed by smooth dehydration of the tertiary alcohol with 80% formic acid in hexane then leads to the tetraenoate ester (XXIV). After reduction of ester (XXIV) with DIBALH and reoxidation of the obtained alcohol to aldehyde with MnO2, the addition of methylmagnesium bromide results in the secondary alcohol (XXV). The deuterium and tritium analogues of (XXV) can be similarly obtained by using the corresponding labeled Grignard reagents. Subsequent oxidation of (XXV) with MnO2 followed by condensation of the resulting methyl ketone with methyl diethylphosphonoacetate leads to the 9-cis-methylretinoate (IIb) (10, 11). Scheme 2.

3 Boehm, M.F., McClurg, M.R., Pathirana, C. et al. Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. J Med Chem 1994, 37(3): 408-14.
4 Bennani, Y.L. An efficient and stereoselective synthesis of 9-cis-retinoic acid. J Org Chem 1996, 61(10): 3542-4.
5 Wada, A., Hiraishi, S., Takamura, N., Date, T., Aoe, K., Ito, M. A novel method for a stereoselective synthesis of trisubstituted olefin using tricarbonyliron complex: A highly stereoselective synthesis of (all-E)- and (9Z)-retinoic acids. J Org Chem 1997, 62(13): 4343-8.
6 Wada, A., Fukunaga, K., Ito, M., Mizuguchi, Y., Nakagawa, K., Okano, T. Preparation and biological activity of 13-substituted retinoic acids. Bioorg Med Chem 2004, 12(14): 3931-42.
7 Pazos, Y., de Lera, A.R. Stereoselective synthesis of 9-cis-retinoic acid by Suzuki reaction. Tetrahedron Lett 1999, 40(47): 8287-90.
8 Pazos, Y., Iglesias, B., de Lera, A.R. The Suzuki coupling reaction in the stereocontrolled synthesis of 9-cis-retinoic acid and its ring-demethylated analogues. J Org Chem 2001, 66(25): 8483-9.
9 Bennani, Y.L., Boehm, M.F. Synthesis of high specific activity 2,3- and 3,4-[3H]2-9-cis-retinoic acid. J Org Chem 1995, 60(5): 1195-200.
10 Tadikonda, P.K., Lacy, J.M., Rigdon, M.G., DeLuca, H.F. Synthesis of 9-cis-retinoic acid and C-20-[3H3C]-9-cis-retinoic acid with high specific activity. J Label Comp Radiopharm 1997, 34(1): 1-10.
11 DeLuca, H.F., Tadikonda, P.K. (Wisconsin Alumni Res. Found.). Method of synthesis of retinoic acid. US 5808120.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(Iia) 65476 9-cis-Retinoic acid ethyl ester; Ethyl (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate   C22H32O2 详情 详情
(IIb) 65477 9-cis-Retinoic acid methyl ester; Methyl (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate   C21H30O2 详情 详情
(V) 65481 (2E,4E)-3-Methyl-5-(2,6,6-Trimethyl-1-Cyclohexenyl)Penta-2,4-Dienal 1209-68-3 C15H22O 详情 详情
(XII) 65488 complex of (2E,4E)-3-Methyl-5-(2,6,6-Trimethyl-1-Cyclohexenyl)Penta-2,4-Dienal with Fe(CO)3   C15H22O.Fe(CO)3 详情 详情
(XIII) 44704 ethyl (E)-4-(diethoxyphosphoryl)-3-methyl-2-butenoate 41891-54-7 C11H21O5P 详情 详情
(XIV) 65489     C28H50Sn 详情 详情
(XV) 65490     C7H9F3O5S 详情 详情
(XVI) 65491 (Z)-3-methylpent-2-en-4-yn-1-ol 105-29-3 C6H8O 详情 详情
(XVII) 65492     C18H34OSn 详情 详情
(XVIII) 65493     C13H17IO2 详情 详情
(XIX) 65494 2,2,6-Trimethylcyclohexanone   C9H15O 详情 详情
(XX) 65495     C11H21BO2 详情 详情
(XXI) 65496     C22H30O2 详情 详情
(XXII) 65497     C15H24O2 详情 详情
(XXIII) 65498     C15H24O2 详情 详情
(XXIV) 65499     C18H26O2 详情 详情
(XXV) 65500     C18H28O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XIII)

The dehydro precursors (XXIa) and (XXIb) are prepared by the following sequences. Allylic bromination of β-cyclocitral (XXXVII) with N-bromosuccinimide in cold CH2Cl2 in the presence of CaO and NaHCO3 followed by elimination of HBr in boiling collidine gives α-safranal (XXXVIII). Subsequent cyclization of aldehyde (XXXVIII) with the lithium carbanion derived from ethyl 3,3-dimethylacrylate (XXXIX) in cold THF provides lactone (XLa). The analogous lactone containing an unconjugated cyclohexadiene ring (XLb) is obtained by MichaelWittig tandem reaction of ethyl 2-isopropylideneacetoacetate (XLI) with the phosphorous ylide derived from allyltriphenylphosphonium chloride (XLII) to produce the cyclic ester (XLIII). Subsequent LiAlH4 reduction of ester (XLIII) followed by Swern oxidation gives aldehyde (XLIV). After isomerization of aldehyde (XLIV) upon treatment with catalytic DBU in CH2Cl2 at room temperature, the isomeric cyclohexadienal (XLV) is condensed with ethyl 3,3-dimethylacrylate (XXXIX) as above to furnish lactone (XLb). Reduction of either lactone (XLa) or (XLb) with DIBALH followed by acid-catalyzed ring opening of the resulting lactols leads to the respective tetraenic aldehydes (XLVIa) and (XLVIb), which undergo Horner-Emmons olefination with diethyl 3-(ethoxycarbonyl)-2-methylprop-2-enylphosphonate (XIII) to furnish the corresponding esters (XXIa) and (XXIb) (9). Scheme 4.

9 Bennani, Y.L., Boehm, M.F. Synthesis of high specific activity 2,3- and 3,4-[3H]2-9-cis-retinoic acid. J Org Chem 1995, 60(5): 1195-200.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(Xla) 65514     C15H20O2 详情 详情
(XLb) 65515     C15H20O2 详情 详情
(XLVIa) 65521     C15H20O 详情 详情
(XLVIb) 65522     C15H20O 详情 详情
(XIII) 44704 ethyl (E)-4-(diethoxyphosphoryl)-3-methyl-2-butenoate 41891-54-7 C11H21O5P 详情 详情
(XXI) 65496     C22H30O2 详情 详情
(XXXVII) 65512 beta-Cyclocitral; 2,6,6-Trimethyl-1-Cyclohexenecarboxaldehyde; Ai3-37227 432-25-7 C10H16O 详情 详情
(XXXVIII) 65513 2,6,6-Trimethyl-1,3-Cyclohexadiene-1-Carboxaldehyde 116-26-7 C10H14O 详情 详情
(XXXIX) 24113 methyl 3-methyl-2-butenoate; Methyl 3,3-dimethylacrylate 924-50-5 C6H10O2 详情 详情
(XLI) 65516 ethyl 2-isopropylideneacetoacetate   C9H14O3 详情 详情
(XLII) 65517 allyltriphenylphosphonium chloride   C21H20ClP 详情 详情
(XLIII) 65518     C12H18O2 详情 详情
(XLIV) 65519     C10H13O 详情 详情
(XLV) 65520     C10H13O 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VI)

Addition of methyllithium to 3,5-di-tert-butylbenzoic acid (I) at -78 C gave acetophenone (II). The Horner-Emmons condensation of acetophenone (II) with diethyl (cyanomethyl)phosphonate (III) resulted in a mixture of isomeric alpha,beta-unsaturated nitriles (IV). After isolation of the major E-isomer by preparative TLC, cyano group reduction employing DIBAL in CH2Cl2 at -78 C provided aldehyde (V). This was subjected to a new Horner-Emmons condensation with phosphonate (VI) to provide the octatrienoate ester (VII). The target carboxylic acid was then prepared by saponification of ester (VII) with methanolic KOH.

1 Zhang, L.; et al.; Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells. J Med Chem 1996, 39, 14, 2659.
2 Boehm, M.F.; Zhang, L.; Bennani, Y.L.; Nadzan, A.M. (Ligand Pharmaceuticals, Inc.); Novel trienoic retinoid cpds. and methods. JP 1998511948; US 5721103; US 6083977; WO 9620913 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IVa) 56192 (E)-3-[3,5-di(tert-butyl)phenyl]-2-butenenitrile C18H25N 详情 详情
(IVb) 56193 (Z)-3-[3,5-di(tert-butyl)phenyl]-2-butenenitrile C18H25N 详情 详情
(I) 56190 3,5-Di-tert-butylbenzoic acid 16225-26-6 C15H22O2 详情 详情
(II) 56191 1-[3,5-di(tert-butyl)phenyl]-1-ethanone C16H24O 详情 详情
(III) 10045 Diethyl cyanomethylphosphonate 2537-48-6 C6H12NO3P 详情 详情
(V) 56194 (E)-3-[3,5-di(tert-butyl)phenyl]-2-butenal C18H26O 详情 详情
(VI) 44704 ethyl (E)-4-(diethoxyphosphoryl)-3-methyl-2-butenoate 41891-54-7 C11H21O5P 详情 详情
(VII) 56195 ethyl (2E,4E,6E)-7-[3,5-di(tert-butyl)phenyl]-3-methyl-2,4,6-octatrienoate C25H36O2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(IX)

The tetrahydronaphthalene derivative (III) was prepared by condensation of 1-bromo-2-ethoxybenzene (II) with 2,5-dichloro-2,5-dimethylhexane (I) in the presence of AlCl3. Lithium-bromine exchange in (III), followed by treatment with trimethyl borate and acid quenching, provided boronic acid (IV). This was subjected to palladium-catalyzed coupling with 3-bromo-3-buten-1-ol (V) to afford the homoallylic alcohol (VI). A Simmons-Smith reaction of (VI) with chloroiodomethane and diethylzinc furnished the cyclopropyl alcohol (VII), which was further oxidized to aldehyde (VIII) employing PCC. Horner-Emmons condensation of aldehyde (VIII) with phosphonate (IX) gave rise to the dienoate ester (X). Finally, basic hydrolysis of the ester function of (X) yielded the corresponding carboxylic acid.

1 Zhi, L.; Farmer, L.J. (Ligand Pharmaceuticals, Inc.); Retinoids, methods for their production and use. US 6005007 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 35216 2,5-dichloro-2,5-dimethylhexane C8H16Cl2 详情 详情
(II) 44697 2-bromophenyl ethyl ether; 1-bromo-2-ethoxybenzene 583-19-7 C8H9BrO 详情 详情
(III) 44698 6-bromo-7-ethoxy-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene; 3-bromo-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl ethyl ether C16H23BrO 详情 详情
(IV) 44699 3-ethoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenylboronic acid C16H25BO3 详情 详情
(V) 44700 3-bromo-3-buten-1-ol C4H7BrO 详情 详情
(VI) 44701 3-(3-ethoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)-3-buten-1-ol C20H30O2 详情 详情
(VII) 44702 2-[1-(3-ethoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)cyclopropyl]-1-ethanol C21H32O2 详情 详情
(VIII) 44703 2-[1-(3-ethoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)cyclopropyl]acetaldehyde C21H30O2 详情 详情
(IX) 44704 ethyl (E)-4-(diethoxyphosphoryl)-3-methyl-2-butenoate 41891-54-7 C11H21O5P 详情 详情
(X) 44705 ethyl (2E,4E)-6-[1-(3-ethoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)cyclopropyl]-3-methyl-2,4-hexadienoate C28H40O3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(XII)

Horner-Emmons condensation of aldehyde (XI) with phosphonate (XII) produced the diene ester (XIII). Finally, ethyl ester hydrolysis of (XIII) gave rise to the title carboxylic acid.

1 Vuligonda, V.; et al.; Enantioselective syntheses of potent retinoid X receptor ligands: Differential biological activities of individuals antipodes. J Med Chem 2001, 44, 14, 2298.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XI) 50533 (1R,2S)-2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)cyclopropanecarbaldehyde C19H26O 详情 详情
(XII) 44704 ethyl (E)-4-(diethoxyphosphoryl)-3-methyl-2-butenoate 41891-54-7 C11H21O5P 详情 详情
(XIII) 50534 ethyl (2E,4E)-3-methyl-5-[(1S,2S)-2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)cyclopropyl]-2,4-pentadienoate C26H36O2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(VIII)

Addition of methyllithium to 3,5-di-tert-butylsalicylic acid (I) affords ketone (II). Wittig condensation of the ortho-hydroxyacetophenone (II) with (carbethoxymethylene)triphenylphosphorane leads to the coumarin derivative (III). Subsequent reductive opening of the lactone ring of (III) by means of LiAlH4 provides diol (IV). The phenolic hydroxyl of (IV) is then alkylated by 1,1-difluoro-2-bromoethane (V) in the presence of CsF to furnish the difluoroethyl ether (VI). Oxidation of the allylic alcohol function of (VI) to aldehyde (VII) is accomplished by treatment with tetrapropylammonium perruthenate and N-methylmorpholine-N-oxide. Wadsworth-Emmons condensation of the unsaturated aldehyde (VII) with phosphonate (VIII) then provides the triene adduct (IX). The ethyl ester group of (IX) is finally hydrolyzed under alkaline conditions to the desired carboxylic acid.

1 Jones, T.K.; Ardecky, R.J.; Boehm, M.F.; Hamann, L.G.; Thompson, A.J.; Michellys, P.-Y.; Tyhonas, J.S.; Faulkner, A.L.; Mapes, C.M.; Chen, J.-H. (Ligand Pharmaceuticals, Inc.); RXR modulators with improved pharmacologic profile. EP 1216221; WO 0119770 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 58864 2-Hydroxy-3,5-di-tert-butylbenzoic acid; 3,5-Di-tert-butylsalicylic acid 19715-19-6 C15H22O3 详情 详情
(II) 58865 1-[3,5-di(tert-butyl)-2-hydroxyphenyl]-1-ethanone C16H24O2 详情 详情
(III) 58866 6,8-di(tert-butyl)-4-methyl-2H-chromen-2-one C18H24O2 详情 详情
(IV) 58867 2,4-di(tert-butyl)-6-[(Z)-3-hydroxy-1-methyl-1-propenyl]phenol C18H28O2 详情 详情
(V) 58868 2-Bromo-1,1-difluoroethane 359-07-9 C2H3BrF2 详情 详情
(VI) 58869 (Z)-3-[3,5-di(tert-butyl)-2-(2,2-difluoroethoxy)phenyl]-2-buten-1-ol C20H30F2O2 详情 详情
(VII) 58870 (Z)-3-[3,5-di(tert-butyl)-2-(2,2-difluoroethoxy)phenyl]-2-butenal C20H28F2O2 详情 详情
(VIII) 44704 ethyl (E)-4-(diethoxyphosphoryl)-3-methyl-2-butenoate 41891-54-7 C11H21O5P 详情 详情
(IX) 58871 ethyl (2E,4E,6Z)-7-[3,5-di(tert-butyl)-2-(2,2-difluoroethoxy)phenyl]-3-methyl-2,4,6-octatrienoate C27H38F2O3 详情 详情

合成路线7

该中间体在本合成路线中的序号:(V)

Alkylation of 2,4-di-tert-butyl-6-iodophenol (I) with bromopropane by means of NaH (1) or CsF (2) provides the corresponding propyl ether (II). Subsequent Suzuki coupling of aryl iodide (II) with 2-formylbenzeneboronic acid (III) leads to the biphenyl aldehyde (IV). This is then condensed with phosphonate (V) producing the dienoate ester (VI). Finally, the ethyl ester group of (VI) is hydrolyzed with LiOH to the target carboxylic acid (1,2).

1 Chen, J-H.; Michellys, P-Y.; Ardecky, R.J.; Tyhonas, J.S.; Leibowitz, M.D.; Liu, S.; Rungta, D.; D'Arrigo, J.; Mais, D.E.; Miller, A.; Grese, T.A.; Mapes, C.M.; Thompson, A.W.; Boehm, M.F.; Ogilvie, K.M.; Karanewsky, D.S.; RXR modulators. Design and synthesis of new RXR-selective phenyl- and pyridine-locked dienoic acids for the treatment of type 2 diabetes. 225th ACS Natl Meet (March 23 2003, New Orleans) 2003, Abst MEDI 262.
2 Jones, T.K.; Ardecky, R.J.; Boehm, M.F.; Hamann, L.G.; Thompson, A.J.; Michellys, P.-Y.; Tyhonas, J.S.; Faulkner, A.L.; Mapes, C.M.; Chen, J.-H. (Ligand Pharmaceuticals, Inc.); RXR modulators with improved pharmacologic profile. EP 1216221; WO 0119770 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 63974 2,4-di(tert-butyl)-6-iodophenol C14H21IO 详情 详情
(II) 63975 1,5-di(tert-butyl)-3-iodo-2-propoxybenzene; 2,4-di(tert-butyl)-6-iodophenyl propyl ether C17H27IO 详情 详情
(III) 45993 2-formylphenylboronic acid 40138-16-7 C7H7BO3 详情 详情
(IV) 63976 3',5'-di(tert-butyl)-2'-propoxy[1,1'-biphenyl]-2-carbaldehyde C24H32O2 详情 详情
(V) 44704 ethyl (E)-4-(diethoxyphosphoryl)-3-methyl-2-butenoate 41891-54-7 C11H21O5P 详情 详情
(VI) 63977 ethyl (2E,4E)-5-[3',5'-di(tert-butyl)-2'-propoxy[1,1'-biphenyl]-2-yl]-3-methyl-2,4-pentadienoate C31H42O3 详情 详情

合成路线8

该中间体在本合成路线中的序号:(IV)

 

1 D Lera AR, Torrado A, Iglesias B,et aL. 1992. Stereospecifc synthesis of 9-demethylretinoids via palladium-catalyzed vinylboronic acid-vinyl iodide cross coupling. Tetrahedro Lett. 33 (41): 6205~6208
2 Dominguez B,Iglesias B, de Lera Angle R. 1998. Tetnenylstannanes in the synthesis of retinoic acid anld its ring-modlified analogues. J Org Chem. 63. 4135~4139
3 Pazas Y, Iglesias B, de Lera Angel R. 2001. The Suzuki coupling reaction in the stereocontrolled synthesis of 9-cis-retinoic acid and its ring-demethylated anaIoguer. J Ore Chem,66(25): 8483~8489(有关9-顺式一维A酸及其衍生物的合成)
4 Trost BM, Sorum MT, Chan C. et aL. 1997. Palladium-catalyzed additions of terminal alkynes to acceptor alkynes, J Am Chem Soc, 119: 698~708
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 66891 (2E,4E,6E,8E)-ethyl 3,7-dimethyl-9-(tributylstannyl)nona-2,4,6,8-tetraenoate   C25H44O2Sn 详情 详情
(I) 65494 2,2,6-Trimethylcyclohexanone   C9H15O 详情 详情
(II) 66889 2,6,6-trimethylcyclohex-1-en-1-yl trifluoromethanesulfonate   C10H15F3O3S 详情 详情
(III) 65492     C18H34OSn 详情 详情
(IV) 44704 ethyl (E)-4-(diethoxyphosphoryl)-3-methyl-2-butenoate 41891-54-7 C11H21O5P 详情 详情
Extended Information